Pacific Blue Cross

Helius Medical Technologies, Inc. Reports Third Quarter 2023 Financial Results

Retrieved on: 
Thursday, November 9, 2023
School, Social services, Pons, Gait, TBI, Patient, HCPCS, UPC, Andreyev, PTAP, Research, HSDT, Wolters Kluwer, Accreditation, Stroke, Rehabilitation, Multiple sclerosis, Letter, Pacific Blue Cross, Pharmaceutical industry, Cryptocurrency, Security (finance), Health insurance, Video game, Helios, Health

NEWTOWN, Pa., Nov. 09, 2023 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (“Helius” or the “Company”), a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance and gait deficits, today announced results for the quarter ended September 30, 2023.

Key Points: 
  • NEWTOWN, Pa., Nov. 09, 2023 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (“Helius” or the “Company”), a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance and gait deficits, today announced results for the quarter ended September 30, 2023.
  • Together with the previously announced Durable Medical Equipment, Prosthetics, Orthotics and Supplies (“DMEPOS”) accreditation, the UPC numbers allow for dual paths of reimbursement.
  • Research and development expenses for the third quarter of 2023 decreased slightly to $722 thousand, compared to $751 thousand in the third quarter of 2022.
  • Total operating expenses for the third quarter of 2023 decreased to $3.1 million, compared to $4.9 million in the third quarter of 2022.

Helius Medical Technologies, Inc. Announces Study Results Demonstrating That PoNS Therapy™ Helps Patients with Traumatic Brain Injury Return to Work

Retrieved on: 
Monday, November 6, 2023
TBI, Insurance, HTC, Headache, Gait, Occupation, Health, Disability, Tongue, Pacific Blue Cross, PBC, Quality of life, Rehabilitation, Pons, HSDT, Patient, Traumatic brain injury, RTW, Nursing, Health care

NEWTOWN, Pa., Nov. 06, 2023 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (“Helius” or the “Company”), a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance and gait deficits, today announced the publication of a white paper demonstrating that rehabilitative treatment with the Portable Neuromodulation Stimulator (“PoNS®”) can drastically improve return-to-work (“RTW”) outcomes for patients suffering from TBI. The report, entitled “Evaluating the Real-World Impact of PoNS Therapy™ on Return-to-Work Outcomes in Individuals on Long-Term Disability due to Traumatic Brain Injury,” was co-sponsored by Pacific Blue Cross (“PBC”) and HealthTech Connex (“HTC”), and performed at the Surrey Neuroplasticity Clinic. The Centre for Neurology Studies collected and analyzed the data and released it in a white paper, which can be found on HTC’s website.

Key Points: 
  • The Centre for Neurology Studies collected and analyzed the data and released it in a white paper, which can be found on HTC’s website .
  • However, its efficacy varies widely, and many patients reach plateaus over time or even lose some function regained through rehabilitation.
  • “In addition to significant improvements in balance and gait disability, PoNS Therapy helped with headache, cognitive, and mental health symptoms.
  • We are pleased to have contributed to this impactful study with our innovative PoNS Therapy and proud of the role this treatment plays in improving the health of TBI patients.”

Pacific Blue Cross Names Sarah Hoffman President and CEO

Retrieved on: 
Thursday, November 24, 2022
Happiness, CUPE, Partnership, Government, Selection Committee, Life, Pacific Blue Cross, Retirement, Disability, Organization, Travel, History, Health, Workplace, Management

VANCOUVER, BC, Nov. 24, 2022 /CNW/ - Following an international executive recruitment process, Pacific Blue Cross is pleased to announce that it has selected Sarah Hoffman as President and Chief Executive Officer, effective January 3, 2023.

Key Points: 
  • VANCOUVER, BC, Nov. 24, 2022 /CNW/ - Following an international executive recruitment process, Pacific Blue Cross is pleased to announce that it has selected Sarah Hoffman as President and Chief Executive Officer, effective January 3, 2023.
  • The Pacific Blue Cross Board of Directors, through its CEO Selection Committee and the support of an external executive search firm, has been engaged in an extensive search for the replacement of retiring President and CEO, John Crawford.
  • "At Pacific Blue Cross, we are honoured to currently serve 1 in 3 British Columbians, the highest membership in the history of the organization.
  • The Pacific Blue Cross Board, the retiring President and CEO and the Executive Leadership Team will ensure a successful and smooth transition of leadership to ensure that Pacific Blue Cross continues to deliver on its mission to improve health and wellbeing for British Columbians.

Elementelle Synergistically Combines Prebiotics and Probiotics

Retrieved on: 
Monday, February 21, 2022
Health, Therapy, Prebiotic (nutrition), Proprietary company, Nutrient, Pacific Blue Cross, CKD, Nutritional science, Probiotic, Bio, Vitamin, Research, CFU-GEMM, Extrapyramidal system, Dietary supplement, Gum arabic

Taking probiotics and prebiotics together especially when targeting the health of specific areas of the body is an activity that falls under microbiome therapeutics .

Key Points: 
  • Taking probiotics and prebiotics together especially when targeting the health of specific areas of the body is an activity that falls under microbiome therapeutics .
  • Taken together (in the right forms and doses), prebiotics and probiotics can work synergistically to boost the health of the gut microbiome.
  • About Elementelle Probiotics: Elementelle Probiotics is a probiotic brand created by Pacific Blue Health, Pty Ltd.
  • The brand's unique product line features highly effective probiotics, prebiotics, and other vitamins and nutrients most of which are presented in easy-to-access, daily doses.

Pacific Blue Cross and Blue Cross Canassurance Form a National Alliance with Blue Cross Life

Retrieved on: 
Thursday, January 2, 2020
Health insurance, Medavie Blue Cross, Insurance, Pacific Blue Cross, Manitoba Blue Cross, Blue Cross, Moncton, Service industries, Financial services, Blue Cross Canada

MONCTON, NB, Jan. 2, 2020 /CNW/ - Blue Cross Life Insurance Company of Canada, Pacific Blue Cross and Blue Cross Canassurance have formed an alliance, to bring together local service and insight, with national expertise and scale, to provide best Life and Living Benefits products and services across Canada.

Key Points: 
  • MONCTON, NB, Jan. 2, 2020 /CNW/ - Blue Cross Life Insurance Company of Canada, Pacific Blue Cross and Blue Cross Canassurance have formed an alliance, to bring together local service and insight, with national expertise and scale, to provide best Life and Living Benefits products and services across Canada.
  • Pacific Blue Cross will continue to offer the same Life and Living Benefits products sold under its policies as a distributor for Blue Cross Life.
  • "Blue Cross Canassurance is very pleased to join Blue Cross Life together with the other Canadian Blue Cross Plan members.
  • The Company is owned by four Shareholders, operating as Alberta Blue Cross, Saskatchewan Blue Cross, Manitoba Blue Cross, and Medavie Blue Cross.

AM Best Comments on Credit Ratings of Blue Cross Life Insurance Company of Canada Following Alliance Agreement

Retrieved on: 
Wednesday, October 2, 2019
Insurance, Professional services, Finance, Economy, Service industries, Pacific Blue Cross, Blue Cross, Insurance, Moncton, AM Best

AM Best has commented that the Credit Ratings (ratings) of Blue Cross Life Insurance Company of Canada (Blue Cross Life) (headquartered in Moncton, New Brunswick, Canada) remain unchanged following the recent announcement that Blue Cross Life has formed an alliance with Pacific Blue Cross, which will become effective Jan. 2, 2020.

Key Points: 
  • AM Best has commented that the Credit Ratings (ratings) of Blue Cross Life Insurance Company of Canada (Blue Cross Life) (headquartered in Moncton, New Brunswick, Canada) remain unchanged following the recent announcement that Blue Cross Life has formed an alliance with Pacific Blue Cross, which will become effective Jan. 2, 2020.
  • Pacific Blue Cross will own one-sixth of Blue Cross Life, and it will transfer a substantial portion of its life and disability inforce business as consideration and operate under the same model as the existing investors of Blue Cross Life.
  • The business model of Blue Cross Life remains unchanged as a manufacturer of life and accident and sickness insurance products, which are distributed by its owners.
  • For additional information regarding the use and limitations of Credit Rating opinions, please view Understanding Bests Credit Ratings .